{
    "type": "ETF",
    "ucits": true,
    "fund_name": "iShares China Large Cap UCITS ETF",
    "investment_objective": "To track the return of the FTSE China 50 Index through capital growth and income",
    "primary_asset_class": "Equity",
    "geographic_focus": "China (Hong Kong Stock Exchange listed companies)",
    "replication_method": "physical",
    "swaps": false,
    "derivatives": false,
    "leverage": false,
    "inverse": false,
    "complex_factors": [],
    "classification": "non-complex",
    "supporting_data": "The ETF aims to replicate the FTSE China 50 Index by holding the underlying equity securities in similar proportions, indicating physical replication. There is no mention of synthetic replication, swap agreements, total return swaps, or derivative counterparty risk as an inherent part of the investment strategy. The Fund may use financial derivatives only for direct investment purposes or risk management, but this is minimal and not a core element of the strategy, so derivatives are marked false. There is no leverage, inverse or amplified exposure. The underlying assets are large-cap, liquid equities listed on the Hong Kong Stock Exchange, with no complex structured products or contingent bonds. The risk profile is medium-high (5 out of 7) reflecting equity market and emerging market risks, not complexity. Costs are straightforward with a TER of 0.74%, no performance fees, and no swap or derivative fees. Securities lending is used but revenue sharing does not increase costs. The PRIIPs KID does not contain any comprehension warnings or complexity flags. The monthly factsheet confirms physical replication and no use of swaps or synthetic structures. Overall, the ETF is a straightforward, physical replication UCITS ETF investing in liquid equities, with no leverage or complex derivative structures, thus classified as non-complex under MiFID II."
}